300 related articles for article (PubMed ID: 33846495)
21. Prediction of anthracycline cardiotoxicity after chemotherapy by biomarkers kinetic analysis.
Garrone O; Crosetto N; Lo Nigro C; Catzeddu T; Vivenza D; Monteverde M; Merlano M; Feola M
Cardiovasc Toxicol; 2012 Jun; 12(2):135-42. PubMed ID: 22189487
[TBL] [Abstract][Full Text] [Related]
22. Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia.
Pillai SS; Pereira DG; Bonsu G; Chaudhry H; Puri N; Lakhani HV; Tirona MT; Sodhi K; Thompson E
Front Pharmacol; 2022; 13():953178. PubMed ID: 36034829
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients.
Broeyer FJ; Osanto S; Suzuki J; de Jongh F; van Slooten H; Tanis BC; Bruning T; Bax JJ; Ritsema van Eck HJ; de Kam ML; Cohen AF; Mituzhima Y; Burggraaf J
Br J Clin Pharmacol; 2014 Nov; 78(5):950-60. PubMed ID: 24844787
[TBL] [Abstract][Full Text] [Related]
24. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.
Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J
Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195
[TBL] [Abstract][Full Text] [Related]
25. Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
Michel L; Mincu RI; Mrotzek SM; Korste S; Neudorf U; Rassaf T; Totzeck M
ESC Heart Fail; 2020 Apr; 7(2):423-433. PubMed ID: 32069386
[TBL] [Abstract][Full Text] [Related]
26. Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.
Frères P; Bouznad N; Servais L; Josse C; Wenric S; Poncin A; Thiry J; Moonen M; Oury C; Lancellotti P; Bours V; Jerusalem G
BMC Cancer; 2018 Jan; 18(1):102. PubMed ID: 29378531
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of global longitudinal strain combined with cardiac biomarkers on early detection of anthracycline-related cardiac dysfunction.
Allam H; Kamal M; Bendary M; Osama A; El Eleimy HA; Bendary A
J Echocardiogr; 2023 Dec; 21(4):165-172. PubMed ID: 37453981
[TBL] [Abstract][Full Text] [Related]
28. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
Yu AF; Manrique C; Pun S; Liu JE; Mara E; Fleisher M; Patil S; Jones LW; Steingart RM; Hudis CA; Dang CT
Oncologist; 2016 Apr; 21(4):418-24. PubMed ID: 26984450
[TBL] [Abstract][Full Text] [Related]
29. [Сurrent views on predictors and biomarkers of early diagnosis of anthracycline-mediated cardiotoxicity in patients with breast cancer (review of literature).].
Kit OI; Gvaldin DY; Omelchuk EP; Timoshkina NN
Klin Lab Diagn; 2020; 65(3):141-148. PubMed ID: 32163687
[TBL] [Abstract][Full Text] [Related]
30. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Adamcova M; Lencova-Popelova O; Jirkovsky E; Mazurova Y; Palicka V; Simko F; Gersl V; Sterba M
Int J Cardiol; 2015 Dec; 201():358-67. PubMed ID: 26310978
[TBL] [Abstract][Full Text] [Related]
31. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
32. The value of left ventricular global longitudinal strain assessed by three-dimensional strain imaging in the early detection of anthracyclinemediated cardiotoxicity.
Mornoş C; Manolis AJ; Cozma D; Kouremenos N; Zacharopoulou I; Ionac A
Hellenic J Cardiol; 2014; 55(3):235-44. PubMed ID: 24862616
[TBL] [Abstract][Full Text] [Related]
33. [Value of cardiac troponin I measurement in prediction of anthracycline-induced cardiotoxicity in breast cancer patients].
Huang WB; Yao GY; Liu MF; Chen RT; Chen LJ; Dong JY; Gu F; Guo ZZ; Ye CS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1047-50. PubMed ID: 21690066
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
Dodos F; Halbsguth T; Erdmann E; Hoppe UC
Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
[TBL] [Abstract][Full Text] [Related]
35. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
36. Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy.
Jacobs JEJ; Greason G; Mangold KE; Wildiers H; Willems R; Janssens S; Noseworthy P; Lopez-Jimenez F; Voigt JU; Friedman P; Van Aelst L; Vandenberk B; Attia ZI; Herrmann J
Eur J Prev Cardiol; 2024 Mar; 31(5):560-566. PubMed ID: 37943680
[TBL] [Abstract][Full Text] [Related]
37. Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.
De Iuliis F; Salerno G; Taglieri L; De Biase L; Lanza R; Cardelli P; Scarpa S
Tumour Biol; 2016 Mar; 37(3):3379-87. PubMed ID: 26449821
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
[TBL] [Abstract][Full Text] [Related]
39. Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
Peddi P; Master SR; Dwary AD; Ravipati HP; Patel AH; Pasam A; Katikaneni PK; Shi R; Burton GV; Chu QD
Breast J; 2019 Jan; 25(1):62-68. PubMed ID: 30592128
[TBL] [Abstract][Full Text] [Related]
40. Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy.
Chen J; Wang L; Wu FF; Sun G
Echocardiography; 2019 Sep; 36(9):1682-1688. PubMed ID: 31503352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
